Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company
01 October 2015
A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.
Related
-
Guitar maker’s German supplier says GDPR will cause US discovery delay
-
Ex-wife of embattled China Medical founder hit by Singapore freezing order
-
Steinhoff adds Lehman administrator as €12bn class action looms
-
Harneys loses a Smith in Hong Kong, adds one in the Caymans
-
Paul Weiss Rifkind Wharton & Garrison
Most Read
- Weil Gotshal & Manges advising as Sears files Chapter 11 in New York
- Torchlight: Cayman winding-up settled, judgment issued anyway on public interest grounds
- Noble’s London hearing sees judicial disquiet
- No more “zombie debt”: new limitation provisions apply retrospectively, Indian Supreme Court rules
- Fairfield investment managers lose BVI indemnity claim
Restructuring in Brazil: Lessons learned and opportunities going forward
2nd Annual GRR Live Hong Kong